Regulatory

FDA Works With Manufacturers to Address Estrogen Patch Shortage

NHS England Expands At-home Cervical Cancer Screening

Milken Institute Report Details Coverage and Reimbursement Barriers in Women’s Health

New Surveys Spotlight Breastfeeding’s Workplace and Mental Health Challenges

American Medical Association Overhauls Maternity Care Billing

Health Insurance Gains Plateau for New Mothers

GE HealthCare Launches AI-Powered Breast Ultrasound

Poll Finds Broad Bipartisan Support for Maternal Healthcare

Natural Cycles Receives Sixth FDA Clearance for AI-Powered Fertility Algorithm

Spotlight Medical Secures CE Mark for AI Breast Cancer Prognostic Test

BrightHeart Receives CE Mark for AI-Powered Prenatal Ultrasound Platform

Alife Health Receives FDA Clearance for AI-Powered Embryo Selection Tool

FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years

FertilAI Receives CE Mark for Predictive AI Platform That Optimizes Fertility Treatment Timing

FDA Clears Waters’ At-Home HPV Self-Collection Kit for Cervical Cancer Screening

Ultrasound AI Receives FDA De Novo Clearance for AI-Powered Delivery Date Prediction

Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer

May Health Receives CE Mark for Anavi System, an In-Office Treatment for PCOS-Related Infertility

BlueWind Medical Receives FDA Clearance for Updated Revi Wearable for Urinary Incontinence

Flow Neuroscience Receives FDA Approval for At-Home Brain Stimulation Device for Depression

Overture Life Receives CE Mark for DaVitri Automated Egg Freezing Platform

Hologic’s Digital Pathology System Gains Expanded CE Marking for Cervical and Breast Cancer Diagnostics

Pulsenmore Receives FDA De Novo Authorization for Home Prenatal Ultrasound Device

Alife Health Receives CE Mark for AI-Powered Embryo Selection Tool